| 1 |
Leazer S, Collen J, Alcover K, Tompkins E, Ambardar S, Allard RJ, Foster B, McNutt R, Leon M, Haynes Z, Bascome M, Williams M, Bunin J, O'Malley PG, Moores LK, Chung KK. Outcomes Associated With Intensive Care and Organ Support Among Patients With COVID-19: A Systematic Review and Meta-Analysis. Mil Med 2023;188:541-6. [PMID: 35639913 DOI: 10.1093/milmed/usac143] [Reference Citation Analysis]
|
| 2 |
Cesta MC, Zippoli M, Marsiglia C, Gavioli EM, Cremonesi G, Khan A, Mantelli F, Allegretti M, Balk R. Neutrophil activation and neutrophil extracellular traps (NETs) in COVID-19 ARDS and immunothrombosis. Eur J Immunol 2023;53:e2250010. [PMID: 36239164 DOI: 10.1002/eji.202250010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Savin IA, Zenkova MA, Sen'kova AV. Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches. Int J Mol Sci 2022;23. [PMID: 36499287 DOI: 10.3390/ijms232314959] [Reference Citation Analysis]
|
| 4 |
Tang Z, Yang Z, Feng H, Zhou X, Mao M. Attenuation of the Severity of Acute Respiratory Distress Syndrome by Pomiferin through Blocking Inflammation and Oxidative Stress in an AKT/Foxo1 Pathway-Dependent Manner. Oxid Med Cell Longev 2022;2022:5236908. [PMID: 36471865 DOI: 10.1155/2022/5236908] [Reference Citation Analysis]
|
| 5 |
Nabeya D, Kinjo T, Ueno S, Setoguchi M, Nishiyama N, Kami W, Arakaki W, Haranaga S, Fujita J. Characteristics of patients with viral infections of the lower respiratory tract: A retrospective study. Medicine (Baltimore) 2022;101:e30819. [PMID: 36197196 DOI: 10.1097/MD.0000000000030819] [Reference Citation Analysis]
|
| 6 |
Hamid K, Ali M, Devasahayam J. Acute Respiratory Distress Syndrome Secondary to Enterovirus-Human-Rhinovirus Infection in an Adult. Cureus 2022. [DOI: 10.7759/cureus.26475] [Reference Citation Analysis]
|
| 7 |
Bölüktaş RP, Üçeriz A, Kalaycioğlu G. Medical Management and Nursing Care of a Patient with Acute Respiratory Distress Syndrome. Bezmialem Science 2022;10:392-397. [DOI: 10.14235/bas.galenos.2021.6278] [Reference Citation Analysis]
|
| 8 |
Nunes-silva C, Vilares AT, Schweitzer V, Castanhinha S, Martins A, Lopes MJ, Ascoli-bartoli T, Canelas G, Keir HR, Cunha F, Silva-pinto A, Rebelo S, Cunha RG, Tavares M. Non-COVID-19 respiratory viral infection. Breathe 2022;18:210151. [DOI: 10.1183/20734735.0151-2021] [Reference Citation Analysis]
|
| 9 |
Heo M, Jeong JH, Ju S, Lee SJ, Jeong YY, Lee JD, Yoo J. Comparison of Clinical Features and Outcomes between SARS-CoV-2 and Non-SARS-CoV-2 Respiratory Viruses Associated Acute Respiratory Distress Syndrome: Retrospective Analysis. JCM 2022;11:2246. [DOI: 10.3390/jcm11082246] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 10 |
Long G, Yang X, Ji C, Dong Y. MicroRNA-128b mediates lipopolysaccharide-induced apoptosis via reactive oxygen species in human pulmonary microvascular endothelial cells. Clinics (Sao Paulo) 2022;77:100020. [PMID: 35305480 DOI: 10.1016/j.clinsp.2022.100020] [Reference Citation Analysis]
|
| 11 |
Juanes-Velasco P, Landeira-Viñuela A, García-Vaquero ML, Lecrevisse Q, Herrero R, Ferruelo A, Góngora R, Corrales F, Rivas JL, Lorente JA, Hernández ÁP, Fuentes M. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS. Front Immunol 2022;13:732197. [PMID: 35154090 DOI: 10.3389/fimmu.2022.732197] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 12 |
Tran A, Mcadams C, Hoff CN, Maddu K, Amin S, Herr KD. Emergency Imaging of Thoracic Infections and Complications. Seminars in Roentgenology 2022;57:30-9. [DOI: 10.1053/j.ro.2021.10.007] [Reference Citation Analysis]
|
| 13 |
Ivester HM, Tupik JD, Nagai-singer MA, Coutermarsh-ott SL, Allen IC. Methods to evaluate virus-mediated acute lung inflammation. Methods in Cell Biology 2022. [DOI: 10.1016/bs.mcb.2021.12.021] [Reference Citation Analysis]
|
| 14 |
Peng Z, Su L, Yang C, Zhang J, Dou R, Sun Z, Yang J, He L, Jiang N, Huang R, Yuan F, Xiao G, Gan Q, Lu Q. Corticosteroids Utilization in the Management of Critically Ill Coronavirus Disease-2019 Pneumonia. J Transl Crit Care Med 2022;4:4. [DOI: 10.4103/jtccm.jtccm-d-21-00011] [Reference Citation Analysis]
|
| 15 |
Revell E, Glasbey M, Brown P. Rhinovirus induced bronchiolitis and ARDS in pregnancy: a case report. BMJ Case Rep 2021;14:e246927. [PMID: 34880041 DOI: 10.1136/bcr-2021-246927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Jung F, Liu JS, Yang SH, Tseng HY, Chou SP, Lin JC, Jow GM. FJU-C28 inhibits the endotoxin-induced pro-inflammatory cytokines expression via suppressing JNK, p38 MAPK and NF-κB signaling pathways. Pharmacol Res Perspect 2021;9:e00876. [PMID: 34669271 DOI: 10.1002/prp2.876] [Reference Citation Analysis]
|
| 17 |
Lin SY, Sung FC, Lin CL, Lin CC, Hsu WH, Liao WC, Ho MW, Lin PC, Hsu CY, Kao CH. Association of antihypertensives during hospitalisation with acute respiratory failure in patients with viral pneumonia: A population-based case-control study. Int J Clin Pract 2021;:e14776. [PMID: 34510649 DOI: 10.1111/ijcp.14776] [Reference Citation Analysis]
|
| 18 |
Evsyutina EP, Dinikina YV, Smirnova AY, Fedulova EE, Tereshina AA, Kirichenko MM, Morozov KA, Gorelov II, Latypov AK, Menshugin IN, Belogurova MB, Mazurok VA. Extracorporeal membrane oxygenation for acute respiratory distress syndrome in a child with central nervous system tumor. Onkogematologiâ 2021;16:81-85. [DOI: 10.17650/1818-8346-2021-16-2-81-85] [Reference Citation Analysis]
|
| 19 |
Ambardar SR, Hightower SL, Huprikar NA, Chung KK, Singhal A, Collen JF. Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic. J Clin Med 2021;10:2452. [PMID: 34205928 DOI: 10.3390/jcm10112452] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 20 |
Cen M, Ouyang W, Zhang W, Yang L, Lin X, Dai M, Hu H, Tang H, Liu H, Xia J, Xu F. MitoQ protects against hyperpermeability of endothelium barrier in acute lung injury via a Nrf2-dependent mechanism. Redox Biol 2021;41:101936. [PMID: 33752110 DOI: 10.1016/j.redox.2021.101936] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 21 |
Fosse JH, Haraldsen G, Falk K, Edelmann R. Endothelial Cells in Emerging Viral Infections. Front Cardiovasc Med 2021;8:619690. [PMID: 33718448 DOI: 10.3389/fcvm.2021.619690] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 22 |
Lonati C, Gatti S, Catania A. Activation of Melanocortin Receptors as a Potential Strategy to Reduce Local and Systemic Reactions Induced by Respiratory Viruses. Front Endocrinol (Lausanne) 2020;11:569241. [PMID: 33362713 DOI: 10.3389/fendo.2020.569241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 23 |
Dai W, Rao R, Sher A, Tania N, Musante CJ, Allen R. A Prototype QSP Model of the Immune Response to SARS-CoV-2 for Community Development. CPT Pharmacometrics Syst Pharmacol 2021;10:18-29. [PMID: 33217169 DOI: 10.1002/psp4.12574] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 24 |
Augustin M, Hallek M, Nitschmann S. [Morphological and molecular changes in the lung of COVID-19 patients]. Internist (Berl) 2020;61:1304-7. [PMID: 33215287 DOI: 10.1007/s00108-020-00897-8] [Reference Citation Analysis]
|
| 25 |
Tan HB, Xiong F, Jiang YL, Huang WC, Wang Y, Li HH, You T, Fu TT, Lu R, Peng BW. The study of automatic machine learning base on radiomics of non-focus area in the first chest CT of different clinical types of COVID-19 pneumonia. Sci Rep 2020;10:18926. [PMID: 33144676 DOI: 10.1038/s41598-020-76141-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 26 |
Chiang CC, Korinek M, Cheng WJ, Hwang TL. Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease. Front Pharmacol 2020;11:572009. [PMID: 33162887 DOI: 10.3389/fphar.2020.572009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 27 |
Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 28 |
Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 29 |
Yang SC, Tsai YF, Pan YL, Hwang TL. Understanding the role of neutrophils in acute respiratory distress syndrome. Biomed J 2020:S2319-4170(20)30149-9. [PMID: 33087299 DOI: 10.1016/j.bj.2020.09.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 36] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 30 |
Pacheco PAF, Faria RX. The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target? Scand J Immunol 2021;93:e12960. [PMID: 32797724 DOI: 10.1111/sji.12960] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 31 |
Yu C, Li L, Tuersun Y, Zhao X, Feng Q, Zhang T, Tay FR, Ma J. Oropharyngeal Secretion as Alternative for SARS-CoV-2 Detection. J Dent Res 2020;99:1199-205. [PMID: 32613877 DOI: 10.1177/0022034520940292] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 32 |
Raza SS, Khan MA. Mesenchymal Stem Cells: A new front emerge in COVID19 treatment. Cytotherapy 2020. [DOI: 10.1016/j.jcyt.2020.07.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 33 |
Ikegami S, Jitsuiki K, Nagasawa H, Nishio R, Yanagawa Y. Suspected Virus-Inducing Severe Acute Respiratory Distress Syndrome Treated by Multimodal Therapy Including Extracorporeal Membrane Oxygenation and Immune Modulation Therapy. Cureus 2020;12:e8768. [PMID: 32714705 DOI: 10.7759/cureus.8768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 34 |
Kohne JG, Flori HR. Risk Factors and Etiologies of Pediatric Acute Respiratory Distress Syndrome. Pediatric Acute Respiratory Distress Syndrome 2020. [DOI: 10.1007/978-3-030-21840-9_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 35 |
Young AY, Shannon VR. Acute Respiratory Distress Syndrome in Cancer Patients. Oncologic Critical Care 2020. [DOI: 10.1007/978-3-319-74588-6_48] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 36 |
Zhou F, Wang Y, Liu Y, Liu X, Gu L, Zhang X, Pu Z, Yang G, Liu B, Nie Q, Xue B, Feng J, Guo Q, Liu J, Fan H, Chen J, Zhang Y, Xu Z, Pang M, Chen Y, Nie X, Cai Z, Xu J, Peng K, Li X, Xiang P, Zhang Z, Jiang S, Su X, Zhang J, Li Y, Jin X, Jiang R, Dong J, Song Y, Zhou H, Wang C, Cao B; CAP-China Network. Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network. Eur Respir J 2019;54:1802406. [PMID: 31164430 DOI: 10.1183/13993003.02406-2018] [Cited by in Crossref: 52] [Cited by in F6Publishing: 153] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 37 |
Lee KH, Yoo SG, Cho Y, Kwon DE, La Y, Han SH, Kim MS, Choi JS, Kim SI, Kim YS, Min YH, Cheong JW, Kim JS, Song YG. Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients. J Microbiol Immunol Infect 2021;54:253-60. [PMID: 31262511 DOI: 10.1016/j.jmii.2019.05.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 38 |
Ngu S, Pervaiz S, Avula A, Chalhoub M. Rhinovirus-induced Rapidly Progressing Acute Respiratory Distress Syndrome in an Immunocompetent Host. Cureus 2019;11:e3997. [PMID: 30989006 DOI: 10.7759/cureus.3997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 39 |
Yoo JW, Ju S, Lee SJ, Cho MC, Cho YJ, Jeong YY, Lee JD, Kim HC. Characteristics and Outcomes of Patients with Pulmonary Acute Respiratory Distress Syndrome Infected with Influenza versus Other Respiratory Viruses. Tuberc Respir Dis (Seoul) 2019;82:328-34. [PMID: 31583874 DOI: 10.4046/trd.2019.0017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Young AY, Shannon VR. Acute Respiratory Distress Syndrome in Cancer Patients. Oncologic Critical Care 2019. [DOI: 10.1007/978-3-319-74698-2_48-1] [Reference Citation Analysis]
|
| 41 |
Weinberger SE, Cockrill BA, Mandel J. Acute Respiratory Distress Syndrome. Principles of Pulmonary Medicine 2019. [DOI: 10.1016/b978-0-323-52371-4.00031-3] [Reference Citation Analysis]
|
| 42 |
Quah J, Jiang B, Tan PC, Siau C, Tan TY. Impact of microbial Aetiology on mortality in severe community-acquired pneumonia. BMC Infect Dis 2018;18:451. [PMID: 30180811 DOI: 10.1186/s12879-018-3366-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
|
